Herbal compounds including those already well-established in traditional Chinese medicine have been increasingly tested in the treatment of various diseases. Recent studies have shown that herbal compounds can be of benefit also for pulmonary silicosis as they can diminish changes associated with silica-induced inflammation, fibrosis, and oxidative stress. Due to a lack of effective therapeutic strategies, development of novel approaches which may be introduced particularly in the early stage of the disease, is urgently needed. This review summarizes positive effects of several alternative plant-based drugs in the models of experimental silicosis with a potential for subsequent clinical investigation and use in future.

Department of Physiology Jessenius Faculty of Medicine in Martin Comenius University in Bratislava Martin Slovak Republic

Zobrazit více v PubMed

ABDELAZIZ RR, ELKASHEF WF, SAID E. Tadalafil reduces airway hyperactivity and protects against lung and respiratory airways dysfunction in a rat model of silicosis. Int Immunopharmacol. 2016;40:530–541. doi: 10.1016/j.intimp.2016.10.007. PubMed DOI

ADAMCAKOVA J, MOKRA D. New insights into pathomechanisms and treatment possibilities for lung silicosis. Int J Mol Sci. 2021;22:4162. doi: 10.3390/ijms22084162. PubMed DOI PMC

ALAM W, KHAN H, SHAH MA, CAULI O, SASO L. Kaempferol as a dietary anti-inflammatory agent: Current therapeutic standing. Molecules. 2020;25:4073. doi: 10.3390/molecules25184073. PubMed DOI PMC

AMARAL-MACHADO L, OLIVEIRA WN, MOREIRA-OLIVEIRA SS, PEREIRA DT, ALENCAR ÉN, TSAPIS N, EGITO EST. Use of natural products in asthma treatment. Evid Based Complement Alternat Med. 2020;2020:1021258. doi: 10.1155/2020/1021258. PubMed DOI PMC

ANG L, SONG E, LEE HW, LEE MS. Herbal medicine for the treatment of Coronavirus Disease 2019 (COVID-19): A systematic review and meta-analysis of randomized controlled trials. J Clin Med. 2020;9:1583. doi: 10.3390/jcm9051583. PubMed DOI PMC

BANDEIRA E, OLIVEIRA H, SILVA JD, MENNA-BARRETO RFS, TAKYIA CM, SUK JS, WITWER KW, PAULAITIS ME, HANES J, ROCCO PRM, MORALES MM. Therapeutic effects of adipose-tissue-derived mesenchymal stromal cells and their extracellular vesicles in experimental silicosis. Respir Res. 2018;19:104. doi: 10.1186/s12931-018-0802-3. PubMed DOI PMC

BARBARIN V, NIHOUL A, MISSON P, ARRAS M, DELOS M, LECLERCQ I, LISON D, HUAUX F. The role of pro- and anti-inflammatory responses in silica-induced lung fibrosis. Respir Res. 2005;6:112. doi: 10.1186/1465-9921-6-112. PubMed DOI PMC

BARNES H, GOH NSL, LEONG TL, HOY R. Silica-associated lung disease: An old-world exposure in modern industries. Respirology. 2019;24:1165–1175. doi: 10.1111/resp.13695. PubMed DOI

BERGSBAKEN T, FINK SL, COOKSON BT. Pyroptosis: host cell death and inflammation. Nat Rev Microbiol. 2009;7:99–109. doi: 10.1038/nrmicro2070. PubMed DOI PMC

CASELEY EA, POULTER JA, RODRIGUES F, McDERMOTT MF IMMUNOME PROJECT CONSORTIUM FOR AUTOINFLAMMATORY DISORDERS (IMMUNAID) Inflammasome inhibition under physiological and pharmacological conditions. Genes Immun. 2020;21:211–223. doi: 10.1038/s41435-020-0104-x. PubMed DOI

CHEN S, CUI G, PENG C, LAVIN MF, SUN X, ZHANG E, YANG Y, GUAN Y, DU Z, SHAO H. Transplantation of adipose-derived mesenchymal stem cells attenuates pulmonary fibrosis of silicosis via anti-inflammatory and anti-apoptosis effects in rats. Stem Cell Res Ther. 2018;9:110. doi: 10.1186/s13287-018-0846-9. PubMed DOI PMC

CHEN XH, SUN RS, HU JM, MO ZY, YANG ZF, JIN GY, GUAN WD, ZHONG NS. Inhibitory effect of emodin on bleomycin-induced pulmonary fibrosis in mice. Clin Exp Pharmacol Physiol. 2009;36:146–153. doi: 10.1111/j.1440-1681.2008.05048.x. PubMed DOI

CHOI EJ. Antioxidative effects of hesperetin against 7,12-dimethylbenz(a)anthracene-induced oxidative stress in mice. Life Sci. 2008;82:1059–1064. doi: 10.1016/j.lfs.2008.03.002. PubMed DOI

CHOI M, BAN T, RHIM T. Therapeutic use of stem cell transplantation for cell replacement or cytoprotective effect of microvesicle released from mesenchymal stem cell. Mol Cells. 2014;37:133–139. doi: 10.14348/molcells.2014.2317. PubMed DOI PMC

CHUNG S, YOON HE, KIM SJ, KIM SJ, KOH ES, HONG YA, PARK CW, CHANG YS, SHIN SJ. Oleanolic acid attenuates renal fibrosis in mice with unilateral ureteral obstruction via facilitating nuclear translocation of Nrf2. Nutr Metab (Lond) 2014;11:2. doi: 10.1186/1743-7075-11-2. PubMed DOI PMC

CUI Y, CHEN LJ, HUANG T, YING JQ, LI J. The pharmacology, toxicology and therapeutic potential of anthraquinone derivative emodin. Chin J Nat Med. 2020;18:425–435. doi: 10.1016/S1875-5364(20)30050-9. PubMed DOI

CULLINAN P, REID P. Pneumoconiosis. Prim Care Respir J. 2013;22:249–252. doi: 10.4104/pcrj.2013.00055. PubMed DOI PMC

DAS S, KUMAR M, NEGI V, PATTNAIK B, PRAKASH YS, AGRAWAL A, GHOSH B. MicroRNA-326 regulates profibrotic functions of transforming growth factor-β in pulmonary fibrosis. Am J Respir Cell Mol Biol. 2014;50:882–892. doi: 10.1165/rcmb.2013-0195OC. PubMed DOI PMC

DOS SANTOS G, KUTUZOV MA, RIDGE KM. The inflammasome in lung diseases. Am J Physiol Lung Cell Mol Physiol. 2012;303:L627–L633. doi: 10.1152/ajplung.00225.2012. PubMed DOI PMC

DU S, LI C, LU Y, LEI X, ZHANG Y, LI S, LIU F, CHEN Y, WENG D, CHEN J. Dioscin alleviates crystalline silica-induced pulmonary inflammation and fibrosis through promoting alveolar macrophage autophagy. Theranostics. 2019;9:1878–1892. doi: 10.7150/thno.29682. PubMed DOI PMC

FEHRHOLZ M, GLASER K, SPEER CP, SEIDENSPINNER S, OTTENSMEIER B, KUNZMANN S. Caffeine modulates glucocorticoid-induced expression of CTGF in lung epithelial cells and fibroblasts. Respir Res. 2017;18:51. doi: 10.1186/s12931-017-0535-8. PubMed DOI PMC

FERREIRA TPT, LIMA JGME, FARIAS-FILHO FA, JANNINI DE SÁ YAP, De ARANTES ACS, GUIMARÃES FV, CARVALHO VF, HOGABOAM C, WALLACE J, MARTINS MA, SILVA PMRE. Intranasal flunisolide suppresses pathological alterations caused by silica particles in the lungs of mice. Front Endocrinol (Lausanne) 2020;11:388. doi: 10.3389/fendo.2020.00388. PubMed DOI PMC

GUAN R, ZHAO X, WANG X, SONG N, GUO Y, YAN X, JIANG L, CHENG W, SHEN L. Emodin alleviates bleomycin-induced pulmonary fibrosis in rats. Toxicol Lett. 2016;262:161–172. doi: 10.1016/j.toxlet.2016.10.004. PubMed DOI

HAMILTON RF, JR, THAKUR SA, HOLIAN A. Silica binding and toxicity in alveolar macrophages. Free Radic Biol Med. 2008;44:1246–1258. doi: 10.1016/j.freeradbiomed.2007.12.027. PubMed DOI PMC

HAN JW, SHIM DW, SHIN WY, HEO KH, KWAK SB, SIM EJ, JEONG JH, KANG TB, LEE KH. Anti-inflammatory effect of emodin via attenuation of NLRP3 inflammasome activation. Int J Mol Sci. 2015;16:8102–8109. doi: 10.3390/ijms16048102. PubMed DOI PMC

HARIJITH A, EBENEZER DL, NATARAJAN V. Reactive oxygen species at the crossroads of inflammasome and inflammation. Front Physiol. 2014;5:352. doi: 10.3389/fphys.2014.00352. PubMed DOI PMC

HIRATA A, MURAKAMI Y, SHOJI M, KADOMA Y, FUJISAWA S. Kinetics of radical-scavenging activity of hesperetin and hesperidin and their inhibitory activity on COX-2 expression. Anticancer Res. 2005;25:3367–3374. PubMed

HOU Y, ZHEN Y, XUE Q, WANG W. Astragaloside IV attenuates TGF-β-mediated epithelial-mesenchymal transition of pulmonary fibrosis via suppressing NLRP3 expression in vitro\ Pharmazie. 2021;76:97–102. doi: 10.1691/ph.2021.0933. PubMed DOI

IRANSHAHI M, REZAEE R, PARHIZ H, ROOHBAKHSH A, SOLTANI F. Protective effects of flavonoids against microbes and toxins: The cases of hesperidin and hesperetin. Life Sci. 2015;137:125–132. doi: 10.1016/j.lfs.2015.07.014. PubMed DOI

JIA X, IWANOWYCZ S, WANG J, SAAOUD F, YU F, WANG Y, HU J, CHATTERJEE S, WANG Q, FAN D. Emodin attenuates systemic and liver inflammation in hyperlipidemic mice administrated with lipopolysaccharides. Exp Biol Med (Maywood) 2014;239:1025–1035. doi: 10.1177/1535370214530247. PubMed DOI PMC

JIANG L, WANG J, JU J, DAI J. Salvianolic acid B and sodium tanshinone II A sulfonate prevent pulmonary fibrosis through anti-inflammatory and anti-fibrotic process. Eur J Pharmacol. 2020;883:173352. doi: 10.1016/j.ejphar.2020.173352. PubMed DOI

KIM KH, LEE MS. Autophagy--a key player in cellular and body metabolism. Nat Rev Endocrinol. 2014;10:322–337. doi: 10.1038/nrendo.2014.35. PubMed DOI

KOLB M, RAGHU G, WELLS AU, BEHR J, RICHELDI L, SCHINZEL B, QUARESMA M, STOWASSER S, MARTINEZ FJ, INSTAGE INVESTIGATORS. Nintedanib plus sildenafil in patients with idiopathic pulmonary fibrosis. N Engl J Med. 2018;379:1722–1731. doi: 10.1056/NEJMoa1811737. PubMed DOI

LASZCZYK MN. Pentacyclic triterpenes of the lupane, oleanane and ursane group as tools in cancer therapy. Planta Med. 2009;75:1549–1560. doi: 10.1055/s-0029-1186102. PubMed DOI

LEE CM, PARK JW, CHO WK, ZHOU Y, HAN B, YOON PO, CHAE J, ELIAS JA, LEE CG. Modifiers of TGF-β1 effector function as novel therapeutic targets of pulmonary fibrosis. Korean J Intern Med. 2014;29:281–290. doi: 10.3904/kjim.2014.29.3.281. PubMed DOI PMC

LI C, LU Y, DU S, LI S, ZHANG Y, LIU F, CHEN Y, WENG D, CHEN J. Dioscin exerts protective effects against crystalline silica-induced pulmonary fibrosis in mice. Theranostics. 2017a;7:4255–4275. doi: 10.7150/thno.20270. PubMed DOI PMC

LI LC, XU L, HU Y, CUI WJ, CUI WH, ZHOU WC, KAN LD. Astragaloside IV improves bleomycin-induced pulmonary fibrosis in rats by attenuating extracellular matrix deposition. Front Pharmacol. 2017b;8:513. doi: 10.3389/fphar.2017.00513. PubMed DOI PMC

LI N, FENG F, WU K, ZHANG H, ZHANG W, WANG W. Inhibitory effects of astragaloside IV on silica-induced pulmonary fibrosis via inactivating TGF-β1/Smad3 signaling. Biomed Pharmacother. 2019;119:1093872019. doi: 10.1016/j.biopha.2019.109387. PubMed DOI

LI N, WU K, FENG F, WANG L, ZHOU X, WANG W. Astragaloside IV alleviates silica-induced pulmonary fibrosis via inactivation of the TGF-β1/Smad2/3 signaling pathway. Int J Mol Med. 2021a;47:16. doi: 10.3892/ijmm.2021.4849. PubMed DOI PMC

LI S, SHAO L, FANG J, ZHANG J, CHEN Y, YEO AJ, LAVIN MF, YU G, SHAO H. Hesperetin attenuates silica-induced lung injury by reducing oxidative damage and inflammatory response. Exp Ther Med. 2021b;21:297. doi: 10.3892/etm.2021.9728. PubMed DOI PMC

LI X, AN G, WANG Y, LIANG D, ZHU Z, TIAN L. Targeted migration of bone marrow mesenchymal stem cells inhibits silica-induced pulmonary fibrosis in rats. Stem Cell Res Ther. 2018;9:335. doi: 10.1186/s13287-018-1083-y. PubMed DOI PMC

LIU F, ZHANG J, QIAN J, WU G, MA Z. Emodin alleviates CCl4-induced liver fibrosis by suppressing epithelial-mesenchymal transition and transforming growth factor-β1 in rats. Mol Med Rep. 2018;18:3262–3270. doi: 10.3892/mmr.2018.9324. PubMed DOI PMC

LIU H, YU H, CAO Z, GU J, PEI L, JIA M, SU M. Kaempferol modulates autophagy and alleviates silica-induced pulmonary fibrosis. DNA Cell Biol. 2019;38:1418–1426. doi: 10.1089/dna.2019.4941. PubMed DOI

LIU J, WU Q, LU YF, PI J. New insights into generalized hepatoprotective effects of oleanolic acid: Key roles of metallothionein and Nrf2 induction. Bioch Pharmacol. 2008;76:922–928. doi: 10.1016/j.bcp.2008.07.021. PubMed DOI

LIU WW, WANG HX, YU W, BI XY, CHEN JY, CHEN LZ, DING L, HAN DM, GUO ZK, LEI YX. Treatment of silicosis with hepatocyte growth factor-modified autologous bone marrow stromal cells: a non-randomized study with follow-up. Genet Mol Res. 2015a;14:10672–10681. doi: 10.4238/2015.September.9.7. PubMed DOI

LIU M, XU Y, HAN X, YIN L, XU L, QI Y, ZHAO Y, LIU K, PENG J. Dioscin alleviates alcoholic liver fibrosis by attenuating hepatic stellate cell activation via the TLR4/MyD88/NF-κB signaling pathway. Sci Rep. 2015b;5:18038. doi: 10.1038/srep18038. PubMed DOI PMC

LOPES-PACHECO M, BANDEIRA E, MORALES MM. Cell-based therapy for silicosis. Stem Cells Int. 2016;2016:5091838. doi: 10.1155/2016/5091838. PubMed DOI PMC

MA H, FENG X, DING S. Hesperetin attenuates ventilator-induced acute lung injury through inhibition of NF-κB-mediated inflammation. Eur J Pharmacol. 2015;769:333–341. doi: 10.1016/j.ejphar.2015.11.038. PubMed DOI

MA S, WANG X, WANG Y, ZUO X. Sodium tanshinone IIA sulfonate improves hemodynamic parameters, cytokine release, and multi-organ damage in endotoxemia rabbits. Med Sci Monit. 2018;24:2975–2982. doi: 10.12659/MSM.909996. PubMed DOI PMC

ØVREVIK J, REFSNES M, LÅG M, HOLME JA, SCHWARZE PE. Activation of proinflammatory responses in cells of the airway mucosa by particulate matter: Oxidant- and non-oxidant-mediated triggering mechanisms. Biomolecules. 2015;5:1399–1440. doi: 10.3390/biom5031399. PubMed DOI PMC

PALIKARAS K, LIONAKI E, TAVERNARAKIS N. Mechanisms of mitophagy in cellular homeostasis, physiology and pathology. Nat Cell Biol. 2018;20:1013–1022. doi: 10.1038/s41556-018-0176-2. PubMed DOI

PANG X, SHAO L, NIE X, YAN H, LI C, YEO AJ, LAVIN MF, XIA Q, SHAO H, YU G, JIA Q, PENG C. Emodin attenuates silica-induced lung injury by inhibition of inflammation, apoptosis and epithelial-mesenchymal transition. Int Immunopharmacol. 2021;91:107277. doi: 10.1016/j.intimp.2020.107277. PubMed DOI

PARDALI E, SANCHEZ-DUFFHUES G, GOMEZ-PUERTO MC, TEN DIJKE P. TGF-β-induced endothelial-mesenchymal transition in fibrotic diseases. Int J Mol Sci. 2017;18:2157. doi: 10.3390/ijms18102157. PubMed DOI PMC

PARHIZ H, ROOHBAKHSH A, SOLTANI F, REZAEE R, IRANSHAHI M. Antioxidant and anti-inflammatory properties of the citrus flavonoids hesperidin and hesperetin: an updated review of their molecular mechanisms and experimental models. Phytother Res. 2015;29:323–331. doi: 10.1002/ptr.5256. PubMed DOI

PENG H, WANG R, DENG H, WANG Y, TANG J, CAO F, WANG J. Protective effects of oleanolic acid on oxidative stress and the expression of cytokines and collagen by the AKT/NF κB pathway in silicotic rats. Mol Med Rep. 2017;15:3121–3128. doi: 10.3892/mmr.2017.6402. PubMed DOI

PHINNEY DG, Di GIUSEPPE M, NJAH J, SALA E, SHIVA S, ST CROIX CM, STOLZ DB, WATKINS SC, DI YP, LEIKAUF GD, KOLLS J, RICHES DW, DEIULIIS G, KAMINSKI N, BOREGOWDA SV, McKENNA DH, ORTIZ LA. Mesenchymal stem cells use extracellular vesicles to outsource mitophagy and shuttle microRNAs. Nat Commun. 2015;6:8472. doi: 10.1038/ncomms9472. PubMed DOI PMC

POLLARD SE, WHITEMAN M, SPENCER JP. Modulation of peroxynitrite-induced fibroblast injury by hesperetin: A role for intracellular scavenging and modulation of ERK signalling. Biochem Biophys Res Commun. 2006;347:916–923. doi: 10.1016/j.bbrc.2006.06.153. PubMed DOI

POLLIER J, GOOSSENS A. Oleanolic acid. Phytochemistr. 2012;77:10–15. doi: 10.1016/j.phytochem.2011.12.022. PubMed DOI

QI Y, ZHAO A, YANG P, JIN L, HAO C. miR-34a-5p Attenuates EMT through targeting SMAD4 in silica-induced pulmonary fibrosis. J Cell Mol Med. 2020;24:12219–12224. doi: 10.1111/jcmm.15853. PubMed DOI PMC

QIAN W, CAI X, QIAN Q, ZHANG W, WANG D. Astragaloside IV modulates TGF-β1-dependent epithelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis. J Cell Mol Med. 2018;22:4354–4365. doi: 10.1111/jcmm.13725. PubMed DOI PMC

QU X, GAO H, ZHAI J, SUN J, TAO L, ZHANG Y, SONG Y, HU T. Astragaloside IV enhances cisplatin chemosensitivity in hepatocellular carcinoma by suppressing MRP2. Eur J Pharm Sci. 2020;148:105325. doi: 10.1016/j.ejps.2020.105325. PubMed DOI

RABOLLI V, LO RE S, UWAMBAYINEMA F, YAKOUB Y, LISON D, HUAUX F. Lung fibrosis induced by crystalline silica particles is uncoupled from lung inflammation in NMRI mice. Toxicol Lett. 2011;203:127–134. doi: 10.1016/j.toxlet.2011.03.009. PubMed DOI

SANTANA FP, PINHEIRO NM, MERNAK MI, RIGHETTI RF, MARTINS MA, LAGO JH, LOPES FD, TIBÉRIO IF, PRADO CM. Evidences of herbal medicine-derived natural products effects in inflammatory lung diseases. Mediators Inflamm. 2016;2016:2348968. doi: 10.1155/2016/2348968. PubMed DOI PMC

SAYAN M, MOSSMAN BT. The NLRP3 inflammasome in pathogenic particle and fibre-associated lung inflammation and diseases. Part Fibre Toxicol. 2016;13:51. doi: 10.1186/s12989-016-0162-4. PubMed DOI PMC

SHAO Q, JIANG C, XIA Y, ZHAO M, ZHANG Q, JIN B, LIU J. Dioscin ameliorates peritoneal fibrosis by inhibiting epithelial-to-mesenchymal transition of human peritoneal mesothelial cells via the TLR4/MyD88/NF-κB signaling pathway. Int J Clin Exp Pathol. 2019;12:867–875. PubMed PMC

SHERGIS JL, WU L, ZHANG AL, GUO X, LU C, XUE CC. Herbal medicine for adults with asthma: A systematic review. J Asthma. 2016;53:650–659. doi: 10.3109/02770903.2015.1101473. PubMed DOI

SISSON TH, CHRISTENSEN PJ, MURAKI Y, DILS AJ, CHIBUCOS L, SUBBOTINA N, TOHYAMA K, HOROWITZ JC, MATSUO T, BAILIE M, NIKAM S, HAZAMA M. Phosphodiesterase 4 inhibition reduces lung fibrosis following targeted type II alveolar epithelial cell injury. Physiol Rep. 2018;6:e13753. doi: 10.14814/phy2.13753. PubMed DOI PMC

SONG L, WENG D, DAI W, TANG W, CHEN S, LI C, CHEN Y, LIU F, CHEN J. Th17 can regulate silica-induced lung inflammation through an IL-1beta-dependent mechanism. J Cell Mol Med. 2014;18:1773–1784. doi: 10.1111/jcmm.12341. PubMed DOI PMC

STAFFORD M, CAPPA A, WEYANT M, LARA A, ELLIS J, JR, WEITZEL NS, PUSKAS F. Treatment of acute silicoproteinosis by whole-lung lavage. Semin Cardiothorac Vasc Anesth. 2013;17:152–159. doi: 10.1177/1089253213486524. PubMed DOI

SUGIMOTO N, SUZUKAWA M, NAGASE H, KOIZUMI Y, RO S, KOBAYASHI K, YOSHIHARA H, KOJIMA Y, KAMIYAMA-HARA A, HEBISAWA A, OHTA K. IL-9 blockade suppresses silica-induced lung inflammation and fibrosis in mice. Am J Respir Cell Mol Biol. 2019;60:232–243. doi: 10.1165/rcmb.2017-0287OC. PubMed DOI

TAN S, CHEN S. Macrophage autophagy and silicosis: Current perspective and latest insights. Int J Mol Sci. 2021;22:453. doi: 10.3390/ijms22010453. PubMed DOI PMC

TAO X, YIN L, XU L, PENG J. Dioscin: A diverse acting natural compound with therapeutic potential in metabolic diseases, cancer, inflammation and infections. Pharmacol Res. 2018;137:259–269. doi: 10.1016/j.phrs.2018.09.022. PubMed DOI

TRENTIN PG, FERREIRA TP, ARANTES AC, CIAMBARELLA BT, CORDEIRO RS, FLOWER RJ, PERRETTI M, MARTINS MA, SILVA PM. Annexin A1 mimetic peptide controls the inflammatory and fibrotic effects of silica particles in mice. Br J Pharmacol. 2015;172:3058–3071. doi: 10.1111/bph.13109. PubMed DOI PMC

TSCHOPP J, SCHRODER K. NLRP3 inflammasome activation: The convergence of multiple signalling pathways on ROS production? Nat Rev Immunol. 2010;10:210–215. doi: 10.1038/nri2725. PubMed DOI

WAGNER L, CRAMER H, KLOSE P, LAUCHE R, GASS F, DOBOS G, LANGHORST J. Herbal medicine for cough: A systematic review and meta-analysis. Forsch Komplementmed. 2015;22:359–368. doi: 10.1159/000442111. PubMed DOI

WAN Y, XU L, WANG Y, TUERDI N, YE M, QI R. Preventive effects of astragaloside IV and its active sapogenin cycloastragenol on cardiac fibrosis of mice by inhibiting the NLRP3 inflammasome. Eur J Pharmacol. 2018;833:545–554. doi: 10.1016/j.ejphar.2018.06.016. PubMed DOI

WANG CH, GAO ZQ, YE B, CAI JT, XIE CG, QIAN KD, DU Q. Effect of emodin on pancreatic fibrosis in rats. World J Gastroenterol. 2007;13:378–382. doi: 10.3748/wjg.v13.i3.378. PubMed DOI PMC

WANG CM, HE QZ, ZHANG RX. Effects of tanshionone to bleomycin induced pulmonary fibrosis of rats on histological changes and production of lipid peroxides and hydroxyproline. (Article in Chinese) Zhonghua Jie He He Hu Xi Za Zhi. 1994;17:308–310. PubMed

WANG T, ZHONG XG, LI YH, JIA X, ZHANG SJ, GAO YS, LIU M, WU RH. Protective effect of emodin against airway inflammation in the ovalbumin-induced mouse model. Chin J Integr Med. 2015;21:431–437. doi: 10.1007/s11655-014-1898-z. PubMed DOI

WANG X, YE XL, LIU R, CHEN HL, BAI H, LIANG X, ZHANG XD, WANG Z, LI WL, HAI CX. Antioxidant activities of oleanolic acid in vitro: possible role of Nrf2 and MAP kinases. Chem Biol Interact. 2010;184:328–337. doi: 10.1016/j.cbi.2010.01.034. PubMed DOI

WU Y, TIAN YJ, LE ML, ZHANG SR, ZHANG C, HUANG MX, JIANG MY, ZHANG B, LUO HB. Discovery of novel selective and orally bioavailable phosphodiesterase-1 inhibitors for the efficient treatment of idiopathic pulmonary fibrosis. J Med Chem. 2020;63:7867–7879. doi: 10.1021/acs.jmedchem.0c00711. PubMed DOI

XIAO M, ZHU T, ZHANG W, WANG T, SHEN YC, WAN QF, WEN FQ. Emodin ameliorates LPS-induced acute lung injury, involving the inactivation of NF-kappaB in mice. Int J Mol Sci. 2014;15:19355–19368. doi: 10.3390/ijms151119355. PubMed DOI PMC

XIE XY, ZHANG B, LI JH, FAN QX, ZHANG Y, MU DG, LI WP, XU M, ZHAO PT, JIN FG, LI ZC. Sodium tanshinone iia sulfonate attenuates seawater aspiration-induced acute pulmonary edema by up-regulating Na(+),K(+)-ATPase activity. Exp Lung Res. 2011;37:482–491. doi: 10.3109/01902148.2011.594144. PubMed DOI

XU T, YAN W, WU Q, XU Q, YUAN J, LI Y, LI P, PAN H, NI C. MiR-326 inhibits inflammation and promotes autophagy in silica-induced pulmonary fibrosis through targeting TNFSF14 and PTBP1. Chem Res Toxicol. 2019;32:2192–2203. doi: 10.1021/acs.chemrestox.9b00194. PubMed DOI

YANG L, REN S, XU F, MA Z, LIU X, WANG L. Recent advances in the pharmacological activities of dioscin. Biomed Res Int. 2019;2019:5763602. doi: 10.1155/2019/5763602. PubMed DOI PMC

YANG T, WANG J, PANG Y, DANG X, REN H, LIU Y, CHEN M, SHANG D. Emodin suppresses silica-induced lung fibrosis by promoting Sirt1 signaling via direct contact. Mol Med Rep. 2016;14:4643–4649. doi: 10.3892/mmr.2016.5838. PubMed DOI PMC

YANG CC, YANG CM. Chinese herbs and repurposing old drugs as therapeutic agents in the regulation of oxidative stress and inflammation in pulmonary diseases. J Inflamm Res. 2021;14:657–687. doi: 10.2147/JIR.S293135. PubMed DOI PMC

YU WN, SUN LF, YANG H. Inhibitory effects of astragaloside IV on bleomycin-induced pulmonary fibrosis in rats via attenuation of oxidative stress and inflammation. Inflammation. 2016;39:1835–1841. doi: 10.1007/s10753-016-0420-5. PubMed DOI

ZAHID A, LI B, KOMBE AJK, JIN T, TAO J. Pharmacological inhibitors of the NLRP3 inflammasome. Front Immunol. 2019;10:2538. doi: 10.3389/fimmu.2019.02538. PubMed DOI PMC

ZHANG T, LIANG Y, ZHANG J. Natural and synthetic compounds as dissociated agonists of glucocorticoid receptor. Pharmacol Res. 2020;156:104802. doi: 10.1016/j.phrs.2020.104802. PubMed DOI

ZHANG WJ, FREI B. Astragaloside IV inhibits NF-kappa B activation and inflammatory gene expression in LPS-treated mice. Mediators Inflamm. 2015;2015:274314. doi: 10.1155/2015/274314. PubMed DOI PMC

ZHANG YM, ZHANG HT, WANG CY, WANG W, WU J, WANG C. Long-term therapeutic effects of whole lung lavage in the management of silicosis. (Article in Chinese) Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2012;30:690–693. PubMed

ZHAO H, WANG Y, QIU T, LIU W, YAO P. Autophagy, an important therapeutic target for pulmonary fibrosis diseases. Clin Chim Acta. 2020;502:139–147. doi: 10.1016/j.cca.2019.12.016. PubMed DOI

ZHOU ZY, ZHAO WR, ZHANG J, CHEN XL, TANG JT. Sodium tanshinone IIA sulfonate: A review of pharmacological activity and pharmacokinetics. Biomed Pharmacother. 2019;118:109362. doi: 10.1016/j.biopha.2019.109362. PubMed DOI

ZHU Z, LI Q, XU C, ZHAO J, LI S, WANG Y, TIAN L. Sodium tanshinone IIA sulfonate attenuates silica-induced pulmonary fibrosis in rats via activation of the Nrf2 and thioredoxin system. Environ Toxicol Pharmacol. 2020;80:103461. doi: 10.1016/j.etap.2020.103461. PubMed DOI